10 April 2008
LiDCO Group Plc, the cardiovascular monitoring company, has appointed Abchurch Communications to provide ongoing financial communications advice.
LiDCO is a leading supplier of minimally invasive hemodynamic monitoring equipment and disposables. These are used primarily for the management of hospital patients requiring critical care or at major cardiovascular risk. LiDCO's computer-based technology significantly reduces the complications (particularly infections) and costs associated with major surgery. The technology was invented in the Department of Applied Physiology based at St Thomas' Hospital, London. LiDCO is based in the UK and its shares are traded on AIM.
Panmure Gordon and Co is Nominated Adviser and broker to the Company.
Tel: +44 (0)20 7398 7700